CT-invented handheld ultrasound plays co-starring role in HBO medical drama ‘The Pitt’
Developed in Guilford, Butterfly Network's handheld scanner saves lives in the emergency room during the latest episode of a popular HBO medical drama.
Precision Medicine Online27m
FDA Approves Telix Radiopharmaceutical Imaging Agent Gozellix to ID PSMA-Positive Prostate Cancer
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Precision Medicine Online1h
FDA Approves Telix's Radiopharmaceutical Imaging Agent Gozellix to Identify PSMA-Positive Prostate Cancer
The PSMA-PET imaging agent will be used for patients who have suspected metastasis and those with suspected cancer recurrence.
Oncology Nursing News2h
FDA Approves TLX007-CDx for Prostate Cancer Imaging
TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...
Silk sponges instead of animal testing: How a 3D cell culture system could advance cancer diagnostics
A consortium of Austrian research groups from the University of Vienna, MedUni Vienna and Technikum Wien, together with ...
Researchers capture first laser-driven, high-resolution CT scans of dense objects
A research team led by Colorado State University has achieved a new milestone in 3D X-ray imaging technology. The scientists ...
Telix Pharmaceuticals Gets FDA Approval for Prostate Cancer Screening Agent
Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...
CURE3h
FDA Approves Gozellix for Advanced PSMA-PET Imaging in Prostate Cancer
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...
The Costs of Research Funding Delays at NIH
The Alzheimer’s Disease Research Center (ADRC) at the University of Pittsburgh is one of the country’s hubs for researchers ...
Targeted Oncology18h
FDA OKs TLX007-CDx in Prostate Cancer Treatment
TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...
Up 113% in a year, guess which ASX 200 healthcare stock just scored another FDA win
The S&P/ASX 200 Index (ASX: XJO) healthcare stock is charging higher again on Friday following another FDA goal.
Small study hints anti-amyloid therapy may keep Alzheimer’s symptoms at bay in certain patients
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...